We are live on
!
Find out more
PCA
Peddock Capital Advisors Portfolio holdings
AUM
$501M
1-Year Est. Return
29.8%
This Fund
S&P 500
This Quarter
Est. Return
-0.9%
1 Year Est. Return
+29.8%
3 Year Est. Return
+104.15%
5 Year Est. Return
+160.2%
10 Year Est. Return
+350.74%
AUM
$163M
AUM Growth
+$5.92M
(+3.8%)
Cap. Flow
+$9.26M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
60.86%
Holding
245
New
153
Increased
38
Reduced
12
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.49M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$966K |
| 3 |
Mastercard
MA
|
+$396K |
| 4 |
HP
HPQ
|
+$353K |
| 5 |
CF Industries
CF
|
+$308K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$2.42M |
| 2 |
Procter & Gamble
PG
|
+$1.84M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$435K |
| 4 |
Danaher
DHR
|
+$120K |
| 5 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$71K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 48.04% |
| 2 | Healthcare | 7.93% |
| 3 | Technology | 7.04% |
| 4 | Financials | 6.14% |
| 5 | Consumer Staples | 5.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
226
Agenus
AGEN
$255M
| $1K | ﹤0.01% |
+8
| New | +$917 |
|
227
Amgen
AMGN
$203B
| $1K | ﹤0.01% |
+6
| New | +$1.01K |
|
228
Citigroup
C
$223B
| $1K | ﹤0.01% |
+26
| New | +$1.18K |
|
229
Salesforce
CRM
$142B
| $1K | ﹤0.01% |
+20
| New | +$1.56K |
|
230
Elevance Health
ELV
$82.1B
| $1K | ﹤0.01% |
+10
| New | +$1.29K |
|
231
MannKind Corp
MNKD
$1.22B
| $1K | ﹤0.01% |
+200
| New | +$884 |
|
232
NextEra Energy
NEE
$185B
| $1K | ﹤0.01% |
+32
| New | +$1.01K |
|
233
PACCAR
PCAR
$70.2B
| $1K | ﹤0.01% |
+18
| New | +$685 |
|
234
Ross Stores
ROST
$78.1B
| $1K | ﹤0.01% |
+22
| New | +$1.35K |
|
235
Texas Instruments
TXN
$255B
| $1K | ﹤0.01% |
+18
| New | +$1.23K |
|
236
Textron
TXT
$16.7B
| $1K | ﹤0.01% |
+20
| New | +$788 |
|
|
MNDT
237
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1K | ﹤0.01% |
+50
| New | +$768 |
|
|
TWX
238
DELISTED
Time Warner Inc
TWX
| $1K | ﹤0.01% |
+12
| New | +$937 |
|
|
MON
239
DELISTED
Monsanto Co
MON
| $1K | ﹤0.01% |
+7
| New | +$734 |
|
|
240
Procter & Gamble
PG
$346B
| – | – |
-21,763
| Closed | -$1.84M |
|
|
EMC
241
DELISTED
EMC CORPORATION
EMC
| – | – |
-16,011
| Closed | -$435K |
|
Similar funds
CWM
HSG
DAC
AA
MCCP
SWA
PRP
MWP
Peddock Capital Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, Peddock Capital Advisors held 245 positions worth $163M, up 3.8% from $157M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
Peddock Capital Advisors deployed $9.26M of net new capital in Q3 2016, opening 153 new positions and adding to 38 existing holdings. Its largest new stake was Allergan Inc: 6,483 shares worth $1.49M.
By sector, the portfolio is most concentrated in Energy at 48% of assets, down from 55% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was ExxonMobil, an estimated $2.42M trimmed.
- Peddock Capital Advisors's largest Q3 2016 buy was Allergan Inc: 6,483 shares worth $1.49M.
- Peddock Capital Advisors added most to Mastercard in Q3 2016, an estimated $396K increase.
- Peddock Capital Advisors's biggest Q3 2016 reduction was ExxonMobil, cutting an estimated $2.42M.
- Peddock Capital Advisors fully exited Procter & Gamble in Q3 2016, selling an estimated $1.84M.
- Peddock Capital Advisors's ten largest holdings make up 61% of its $163M portfolio in Q3 2016.
- Peddock Capital Advisors opened 153 new positions and closed 2 in Q3 2016.
- Peddock Capital Advisors's portfolio value rose 3.8% quarter-over-quarter to $163M.
Based on Peddock Capital Advisors's 13F filing for Q3 2016, filed 14 Oct 2016.